Novartis Annual Report 2016 - Corporate Responsibility-PDF Free Download

https://www.novartis.com/sites/www.novartis.com/files/ar-2016-corporate-responsibility-en.pdf

>>Novartis Annual Report 2016 - Corporate Responsibility-PDF Free Download Pdf [Fast DOWNLOAD]<<


Related Books

Novartis Annual Report 2016 - Corporate Responsibility

Novartis Annual Report 2016 - Corporate Responsibility

tackling infectious diseases and are ill-equipped to address the needs of patients with chronic illnesses. This cannot be solved by one organization alone, so we partner with organizations that can contribute their skills and capabilities. Our distribution partners include MEDS and the Kenya Red Cross. We are also working with Management Sciences for Health to assess the supply chains in ...

Continue Reading...
Novartis Annual Report 2017

Novartis Annual Report 2017

more than 70 new molecules in areas of high unmet medical need such as cancer, respiratory disease and heart disease. Joerg Reinhardt. ... the World” list in 2017, and we moved to fourth in the 2017 Dow Jones Sustainability Index World, up from seventh in 2016. We continued to expand our efforts to eliminate malaria, for example by working with Medicines for Malaria Venture to initiate a ...

Continue Reading...
NOVARTIS INDIA LIMITED ANNUAL REPORT 2016-17

NOVARTIS INDIA LIMITED ANNUAL REPORT 2016-17

In August 2015, Novartis signed a new Memorandum with WHO, extending the provision of multidrug therapy (MDT) free of charge to all leprosy patients worldwide until the end of 2020; the Company’s collaboration with WHO began in 2000, and was renewed twice, in 2005 and 2010. The year 2016 marked 30 years of Novartis Foundation’s commitment to support the leprosy-afflicted. I thank you for ...

Continue Reading...
Novartis Annual Report 2016

Novartis Annual Report 2016

In an effort to build Novartis into a company that can thrive no matter what the future holds, we made significant changes in 2016 to create a more sustainable company Last year we reshaped Novartis from a group of loosely affiliated divisions into an integrated company, consoli-dating several functions. We created a Global Drug

Continue Reading...
Novartis Annual Report 2016

Novartis Annual Report 2016

CHAIRMAN’S LETTER Novartis Annual Report 2016 | 3 and immuno-oncology. Partnerships are also vital for our activities in digital health, where we are working to improve evidence-based information about our products and to continue exploring pay-for-performance pricing models. Improving access to healthcare in developing coun- tries is a priority for us, and we are playing our part in helping ...

Continue Reading...
Novartis 2016 and 2015 Financials Updated Segment Reporting

Novartis 2016 and 2015 Financials Updated Segment Reporting

Novartis 2016 and 2015 Financials Updated Segment Reporting Novartis AG. Summary – Updated 2015, 2016 and 2017 Segment Financial Reporting 2 | Updated Segment Reporting | November 2018 In April 2018, following announcements of decisions to move the ophthalmic over the counter (OTC) products1, together with a small portfolio of surgical diagnostics products2, from the Innovative Medicines ...

Continue Reading...
NOVARTIS INDIA LIMITED ANNUAL REPORT 2016-17

NOVARTIS INDIA LIMITED ANNUAL REPORT 2016-17

Members are requested to bring their copy of the Annual Report to the meeting. Members are also requested to direct all correspondence relating to shares to the Company’s Registrar and Transfer Agents, Link Intime India Private Limited, at the address above. 01 NOVARTIS INDIA LIMITED annual report 2016 - 2017

Continue Reading...
Novartis Annual Report 2015

Novartis Annual Report 2015

260 Key Dates 2016, Contact Information and Forward-Looking Statements CONTENTS. 2 | Novartis Annual Report 2015 Dear shareholder, In 2015, Novartis completed a portfolio transformation to focus on three leading divisions, strengthen our pharmaceuticals operation, and leverage our new services organization to improve productivity and profitability. We also achieved important milestones in ...

Continue Reading...
NoVarTIS INdIa LImITed aNNuaL reporT 2015-16

NoVarTIS INdIa LImITed aNNuaL reporT 2015-16

NoVartis iNdia LiMited 04 annual report 2015 - 2016 dear shareholder Novartis has a long-term commitment to ensure access to medicines. in an interconnected and shrinking world that has seen unprecedented levels of disruption in most industries, the pharmaceutical industry particularly lives in extraordinarily volatile times.

Continue Reading...
Novartis Annual Report 2019

Novartis Annual Report 2019

Novartis delivered strong performance in 2019. New product launches together with a disciplined focus on costs and operational efficiency helped us increase sales, operating income and operating profit margin. Looking ahead, we are well positioned to continue our growth trajectory as we pursue our goal of driving sci-ence-based medical innovation. With the successful spin-off of our former eye ...

Continue Reading...
Stichting Access to Medicine Foundation Annual Report 2016

Stichting Access to Medicine Foundation Annual Report 2016

Stichting Access to Medicine Foundation - Annual Report 2016 Table of contents Executive Board Report 3 Summary of the Audited Financial Statements 2016 11 Balance sheet as at 31 December 2016 12 Statement of income and expenses for the year ended 31 December 2016 13 Notes to the Summary of the Audited Financial Statements 2016 14

Continue Reading...